Screening ABL1 kinase domain mutations in patients with de novo Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL)

He LiDepartment of Hematology, Hematologic Research Laboratory, West China Hospital of Sichuan University, Chengdu, P.R. China; Correspondence[email protected]

Wanhua ZhangDepartment of Hematology, Hematologic Research Laboratory, West China Hospital of Sichuan University, Chengdu, P.R. China;

Dongni YiDepartment of Hematology, Hematologic Research Laboratory, West China Hospital of Sichuan University, Chengdu, P.R. China;

Yuanxin YeDepartment of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, P.R. China;

Xueqiu XiaoWest China School of Medicine, Sichuan University, Chengdu, P.R. China

Click to increase image sizeClick to decrease image size

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at http://dx.doi.org/10.1080/10428194.2016.1225205.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Screening ABL1 kinase domain mutations in patients with de novo Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL)

Information for

Open access

Opportunities

Help and information

Screening ABL1 kinase domain mutations in patients with de novo Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL)

Potential conflict of interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature